The following information is exclusively reserved for physicians practicing in the United Kingdom where the Zio™ XT ECG monitoring service is currently authorised and made available for use in accordance with local regulatory requirements.

Click here to see the full report
Support
Support
Search

See the report with 99% clinician agreement1

Zio patient report

Easy navigation, rich summary, and AI*-generated interpretations give clinicians the confidence to make an accurate diagnosis.

Download full sample report

Reporting

Recorded ECG data is processed for the detection of arrhythmias using our UKCA-marked advanced AI, Zio™ ECG Utilization Service (ZEUS) system that can detect up to 13 different types of arrhythmias, plus sinus and artifact. The data is then curated by Qualified ECG Specialists (QES) to generate a Zio end-of-wear report.2-5
 
 
  1. The Zio® Report cover page provides a snapshot of actionable and clinically significant findings.  The upper right hand corner of the report details the wear time and the total analyzable time with artifacts removed. 
  2. Representative ECG strips are arranged in order of clinical significance with additional at-a-glance information such as duration, episodes, and burdens.
  3. Navigate with one click from the cover page to any of the report sections for more details. Download the report for full experience.
  4. Preliminary findings in the Zio report are intended for use by clinicians as an aid in arrhythmia diagnosis and management.
Contact Us
*Zio™ ECG Utilization Service (ZEUS) System

  1. 99% of physicians agree with the comprehensive end-of-wear report. Based on a review of all online Zio XT, Zio monitor, and Zio AT end-of-wear reports. Data on file. iRhythm Technologies, 2023.

  2. Data on file. iRhythm Technologies, 2020.
  3. Hannun et al. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med. 2019;25:65-69. https://doi.org/10.1038/s41591-018-0268-3
  4. Deep learned algorithm is only available in the United States, the European Union, Switzerland, the United Kingdom, and Japan. ​
  5. FDA 510K clearance, CE mark, UKCA mark, and PMDA-approval.

The Zio™ service is a long-term continuous ambulatory cardiac monitoring service. It consists of the Zio™ XT that collects beat-to-beat ECG data and can be worn for up to 14 days; the Zio™ ECG Utilization Service (ZEUS) System, deep learned algorithm that detects arrhythmias. The data is reviewed and curated by a team of Qualified ECG Specialists (QES) to provide the final patient report

For indications for use, warnings & contraindications, visit here

iRhythm, Zio, Zio XT, MyZio, and ZioSuite are trademarks of iRhythm Technologies, Inc. ©2026 All rights reserved.

Zio™ XT and ZEUS are UKCA-marked (UKCA0086)

For further regulatory information, visit here

WEB0059.03